Enhancement of the response to purinergic agonists in P2Y1transfected 1321N1 cells by antagonists suramin and PPADS
Open Access
- 1 March 1997
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 120 (6) , 1049-1052
- https://doi.org/10.1038/sj.bjp.0701010
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia CellsJournal of Biological Chemistry, 1996
- PPADS and suramin as antagonists at cloned P2Y‐ and P2U‐purinoceptorsBritish Journal of Pharmacology, 1996
- Cloning, Functional Expression and Tissue Distribution of the Human P2Y6ReceptorBiochemical and Biophysical Research Communications, 1996
- Cloning and Functional Expression of a Human Uridine Nucleotide ReceptorJournal of Biological Chemistry, 1995
- PPADS: an antagonist at endothelial P2Y‐purinoceptors but not P2U‐purinoceptorsBritish Journal of Pharmacology, 1995
- Pharmacological selectivity of the cloned human P2U‐purinoceptor: potent activation by diadenosine tetraphosphateBritish Journal of Pharmacology, 1995
- Cloning and Characterization of a Bovine P2Y Receptor ∮Biochemical and Biophysical Research Communications, 1995
- G protein-coupled P2 purinoceptors: from molecular biology to functional responsesTrends in Pharmacological Sciences, 1995
- PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responsesEuropean Journal of Pharmacology, 1992
- Suramin antagonizes responses to P2‐purinoceptor agonists and purinergic nerve stimulation in the guinea‐pig urinary bladder and taenia coliBritish Journal of Pharmacology, 1990